Lassa fever, also known as Lassa haemorrhagic fever, is a viral haemorrhagic fever caused by the Lassa virus [1][2]. The Lassa virus is a member of the Arenaviridae family and was first described in 1969 from a case identified in the town of Lassa, in Borno State, Nigeria [1].
Disease overview
Lassa
拉沙热
Lassa fever is a viral haemorrhagic fever caused by the Lassa virus, a member of the Arenaviridae family, and is endemic in rodent populations across several West African countries including Sierra Leone and Nigeria [1][2]. The disease is of growing public-health concern because of increasingly frequent outbreaks, the potential geographic expansion of its Mastomys natalensis reservoir, the emergence of novel viral strains in densely populated regions, and the risk of importation into non-endemic areas [2]. As of the time of the reviewed evidence, no vaccine has been approved for human use, and fundamental gaps in immunology, epidemiology, ecology, and pathogenesis persist [2].
Read the full clinical and epidemiological profile6
Many individuals infected with Lassa virus do not develop symptoms, and when illness occurs it typically begins with fever, weakness, headaches, vomiting, and muscle pains [1]. Less commonly, patients may experience bleeding from the mouth or gastrointestinal tract, and the risk of death once infected is about one percent, frequently occurring within two weeks of symptom onset [1]. Among survivors, approximately one quarter experience hearing loss, which improves within three months in roughly half of these cases [1].
Lassa virus is endemic in rodent populations in Sierra Leone, Nigeria, and other countries in West Africa, with spillover to humans occurring frequently and resulting in a viral haemorrhagic fever associated with a high case-fatality rate [2]. The 2018 outbreak was the largest Lassa fever outbreak recorded; it spread to 18 of Nigeria's states and resulted in 3,498 infections and 171 deaths, with Nigeria accounting for over half of the total regional cases and fatalities [1]. That year, Sierra Leone reported 129 infections and 12 deaths, with the outbreak especially severe in Kenema and Bo Districts, while Guinea experienced 98 cases and 8 fatalities and was among the least affected countries in the region [1]. Public-health authorities have highlighted concerns about more frequent outbreaks, the potential for further geographic expansion of Mastomys natalensis and other rodent reservoirs, and the emergence of novel LASV strains in densely populated West African settings [2].
Lassa fever is usually spread to humans via contact with the urine or faeces of an infected multimammate mouse (Mastomys natalensis), after which person-to-person transmission can occur through direct contact [1].
There is no approved vaccine for Lassa virus, making prevention dependent on isolation of infected individuals and reducing contact with reservoir rodents [1][2]. Recommended measures include storing food in sealed containers to limit rodent access and keeping cats to hunt vermin [1]. Community awareness initiatives promoting hygiene practices, early intervention measures, and stringent border screenings have been employed during outbreaks to limit further spread [1].
- 1Wikipedia contributors. Lassa fever - Wikipedia [Internet]. Wikipedia. cited 2 Sept 2026.Available from: https://en.wikipedia.org/wiki/Lassa_fever
- 2Garry RF et al. Lassa fever - the road ahead. Nat Rev Microbiol. 2023 Feb. PMID: 36097163. doi: 10.1038/s41579-022-00789-8.PubMed: https://pubmed.ncbi.nlm.nih.gov/36097163/
- A96.2
- 1D61
Coverage
Reporting countries and regions
Trends by reporting country
Monthly patterns over time
Research Radar
Recent related research
Temporal dynamics, climate associations, and surveillance performance of Lassa fever in Nigeria, 2020–2025: a national longitudinal analysis
Osong Public Health and Research Perspectives
Lassa fever and Argentine hemorrhagic fever treatment in guinea pigs using broad-spectrum cap-dependent endonuclease inhibitors
mBio
Nosocomial Outbreak of Lassa Fever in Conakry, Guinea, 2022.
The Journal of infectious diseases
Burden of Lassa fever disease in pregnant women and children and options for prevention
Vaccine
Development of a non-infectious control for viral hemorrhagic fever PCR assays
PLOS Neglected Tropical Diseases
Literature links are provided for discovery and do not alter or validate the surveillance series above.
Data access
Page dataset index with source links and update metadata.
Official sourcesAuthority, cadence, notes7
China CDC Weekly
China
Monthly notifiable infectious disease reports published by China CDC.
National Disease Control and Prevention Administration
China
Official China public health bulletin and query portal.
PubMed
China
Biomedical literature discovery feed used as supplementary context.
JP NIID Weekly
Japan
Japan weekly infectious disease surveillance via NIID/JIHS.
Korea KDCA EID
South Korea
Korea KDCA notifiable infectious disease OpenAPI or portal/KOSIS downloads aggregated to national monthly notification counts.
US CDC NNDSS
United States
CDC National Notifiable Diseases Surveillance System provisional data.
US CDC NHSS HIV
United States
CDC NNDSS weekly data plus NHSS annual national HIV diagnoses